CPC petition
This article was originally published in The Rose Sheet
Executive Summary
Objections by Schering-Plough to include .05% cetylpyridium chloride nasal spray as Category I for safety and efficacy in the Oral Antiseptic Drug Products Tentative Final Monograph support the reopening of the administrative record, SinoFresh asserts in Oct. 12 comments to FDA, citing Schering's conclusions that CPC is safe for use in the oral cavity and effective in suppressing superinfective organisms. Schering submitted comments to FDA in July arguing the nasal spray should not be included in the TFM. SinoFresh also cited approval of CPC in April as an antimicrobial agent in poultry processing, and FDA's request for comments on topically applied nasal decongestants carrying sinusitis claims and nasal moisturizers as a reason to reopen the docket. The firm submitted a citizen petition to the agency seeking inclusion of the nasal spray in the TFM in 2003 (1"The Rose Sheet" April 7, 2003, p. 10)...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.